13 research outputs found
Nubia’s mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
Effect of Mass Artesunate-Amodiaquine Distribution on Mortality of Patients With Ebola Virus Disease During West African Outbreak
- Author
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
Recent Advances in the Diagnosis and Management of Ebola Virus Disease
- Author
- Arnemo
- Broadhurst
- Caitlin N. Murphy
- Centers for Disease Control and Prevention
- Cnops
- Gay-Andrieu
- Henao-Restrepo
- Jansen van Vuren
- Johnson
- Kennedy
- Longini
- Makiala
- Mari Saez
- Metzger
- Nguyen
- Oestereich
- PREVAIL II Writing Group
- Qiu
- Semper
- Sissoko
- Southern
- Su
- United States National Library of Medicine
- United States National Library of Medicine
- Van den Bergh
- Weller
- Winslow
- Wonderly
- World Health Organization
- World Health Organization
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Master protocol trials in oncology: Review and new trial designs
- Author
- Armado
- Barker
- Bateman
- Berry
- Berry
- Berry
- Berry
- Billingham
- Brahmer
- Catennaci
- Chapman
- Chen
- Chow
- Chu
- Chu
- Cunanan
- Cunanan
- Freidlin
- Freidlin
- Freidlin
- Freidlin
- Galbraith
- Ghosh
- Heinrich
- Hobbs
- Hyman
- Hyman
- Jonker
- Kaizer
- Kim
- Kim
- Korn
- Korn
- Le Tourneau
- LeBlanc
- Lin
- Liu
- Liu
- Lopez-Chavez
- Maemondo
- Malik
- Mandrekar
- Menis
- MRC Clinical Trials Unit
- National Cancer Institute
- National Cancer Institute
- Neuenschwander
- Park
- Perez
- Randomized Embedded
- Redig
- Redman
- Renfro
- Renfro
- Ritchie
- Robert
- Saville
- Shaw
- Shaw
- Shaw
- Shaw
- Simon
- Simon
- Simon
- Simon
- Slamon
- Swain
- Takebe
- Thall
- The PREVAIL II writing group for the Multi-National PREVAIL II Study Team
- Ventz
- Vogelstein
- Weinstein
- Weinstein
- Woodcock
- Yuan
- Zhou
- Zhou
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Achieving cross-reactivity with pan-ebolavirus antibodies
- Author
- Albariño
- Aleksandrowicz
- Baron
- Beniac
- Bornholdt
- Bornholdt
- Chandran
- Corti
- Dias
- Dye
- Favier
- Flyak
- Flyak
- Flyak
- Flyak
- Formenty
- Formenty
- Furuyama
- Fusco
- Geisbert
- Gilchuk
- Goldstein
- Gregory
- Henao-Restrepo
- Holtsberg
- Howell
- Janus
- King
- King
- Koellhoffer
- Kondratowicz
- Lee
- Lee
- Lee
- MacNeil
- Maruyama
- Mehedi
- Miller
- Milligan
- Mire
- Misasi
- Nanbo
- Pascal
- PREVAIL II Writing Group
- Qiu
- Ren
- Reynard
- Saeed
- Sanchez
- Saphire
- Shedlock
- Shoemaker
- Sobarzo
- Takada
- Towner
- Wec
- Weissenhorn
- West
- Wilson
- Zhang
- Zhao
- Zhao
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19
- Author
- China Business Journal
- Chinese Pharmacopoeia Commission
- Chinese Society of Cardiology
- Karina K.H. Chan
- Leonard T.F. Ho
- National Administration of Traditional Chinese Medicine
- National Administration of Traditional Chinese Medicine
- National Administration of Traditional Chinese Medicine
- National Administration of Traditional Chinese Medicine
- National Copyright Administration of the People’s Republic of China
- Palmar
- The Government of the United Kingdom
- The PREVAIL II Writing Group for the Multi-National PREVAIL II Study Team
- The State Council of the People’s Republic of China
- Ting Hung Leung
- United States Copyright Office
- Vincent C.H. Chung
- World Federation of Chinese Medicine Societies
- World Federation of Chinese Medicine Societies
- World Federation of Chinese Medicine Societies
- World Health Organization
- World Health Organization
- Wu
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials
- Author
- A Muehlenbachs
- A Thorson
- Abha Saxena
- AC Mastroianni
- AD Lyerly
- AM Henao-Restrepo
- Annette C. Kuesel
- CQ Bai
- DG Bausch
- DG Bausch
- DJ Jamieson
- E Akerlund
- GD Maganga
- GP Kobinger
- H Bower
- J Dunning
- J Dunning
- J Dörnemann
- JE Martin
- JM Nelson
- JS Schieffelin
- K Mupapa
- KE Shields
- LB Holmes
- Medicins Sans Frontières
- Melba F. Gomes
- MO Little
- MP Adam
- MP Fallah
- P Francesconi
- P Howlett
- P Vetter
- PREVAIL II Writing Group Multi-National PREVAIL II Study Team
- R Fowler
- R Macklin
- R Merkatz
- RB Merkatz
- RB Merkatz
- RB Merkatz
- Report of an International Commission
- S Baize
- S Caluwaerts
- S Caluwaerts
- S Caluwaerts
- S Duraffour
- SM Jones
- T Kratz
- T Oduyebo
- TW Geisbert
- TW Geisbert
- Vânia de la Fuente-Núñez
- WHO/International Study Team
- World Health Organization
- World Health Organization
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection
- Author
- Alvarez
- Andrea Marzi
- Asuka Nanbo
- Ayato Takada
- Bai
- Baseler
- Basler
- Cagigi
- Cardile
- Carette
- Côté
- Ebihara
- Emanuel
- Furuyama
- Furuyama
- Geisbert
- Goldstein
- Heinz Feldmann
- Hiroko Miyamoto
- Hunt
- Jasenosky
- Johansen
- King
- Kondoh
- Kondratowicz
- Kosuke Okuya
- Kuroda
- Makoto Kuroda
- Manabu Igarashi
- Mao Isono
- Masahiro Kajihara
- Masahiro Sakaitani
- Mbala-Kingebeni
- Miller
- Misasi
- Nakayama
- Nakkazi
- Nanbo
- NIH
- Noda
- Rashid Manzoor
- Reiko Yoshida
- Ren
- Rollin
- Saeed
- Sahul Hameed
- Saito
- Salata
- Schornberg
- Shaikh
- Shoemaker
- Sissoko
- Takada
- Takada
- Takada
- Takamatsu
- Tariq
- Tatsunari Kondoh
- The PREVAIL II Writing Group
- Tiller
- Wakako Furuyama
- Warren
- WHO
- WHO
- Zhang
- Zhao
- Zhao
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Disaster Preparedness: Biological Threats and Treatment Options
- Author
- Abbink
- Adalja
- American Pharmacists Association
- American Society of Health-System Pharmacists
- Anantpadma
- Andrei
- Arnon
- Arnon
- Athamna
- Atkinson
- Bai
- Bishop
- Booth
- Borio
- Bower
- Bradley
- Brasil
- Cangene Corp
- Cangene Corp
- Centers for Disease Control and Prevention
- Centers for Disease Control and Prevention (CDC)
- Centers for Disease Control and Prevention (CDC)
- Cohen
- D'Ortenzio
- Dellinger
- Dennis
- Dowd
- Elusys
- Emergent BioDefense Operations Lansing LLC
- Fagan
- Frieden
- Geisbert
- GlaxoSmithKline
- Grubaugh
- Hanczaruk
- Henao-Restrepo
- Henao-Restrepo
- Henderson
- Hendricks
- Hill
- Hodowanec
- Hou
- Inglesby
- Jernigan
- Jorgenson
- Katharios-Lanwermeyer
- Khabbaz
- Kool
- Kretzschmar
- Kwit
- Larocca
- Martin
- Mead
- Meselson
- Meyerhoff
- Migone
- Migone
- Miller
- Mlakar
- Morens
- Morens
- Mucker
- Mwengee
- Mytle
- Nalca
- Nicastri
- Olson
- Penn
- Petersen
- Petersen
- Reardon
- Rhodes
- Runfola
- Singer
- Spengler
- Stanley
- Stevens
- Taubenberger
- Tebas
- The PREVAIL II Writing Group for the Multi-National PREVAIL II Study Team
- Treanor
- Trost
- Tunkel
- Turmel
- USAMIIRD
- Wheelis
- Woodard
- World Health Organization
- Wright
- Yamamoto
- Zhu
- Zhu
- Zimmer
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Monoclonal antibodies as anti-infective products: a promising future?
- Author
- A. Cavaleiro Sanches
- Baer
- Balasingam
- Bebbington
- Berry
- Bloom
- Brambery
- Buss
- Caliendo
- Cameron
- Canini
- Checchia
- Corti
- Darton
- Digiandomenico
- E. Pelfrene
- Ecker
- European Medicines Agency
- European Medicines Agency
- European Medicines Agency
- François
- Friesen
- Froude
- Gogtay
- Graham
- Henrich
- Hey
- Hua
- Huang
- Jacobson
- Klein
- Lehar
- Lynch
- Lyon
- M. Cavaleri
- M. Mura
- Marston
- Migone
- Modjarrad
- Montefiori
- Nagy
- Norman
- Nougairede
- Nuñez-Prado
- Patel
- Paules
- Prabakaran
- PREVAIL II Writing group
- Que
- Ramos
- Regnstrom
- Salazar
- Saylor
- Sevigny
- Soares
- Song
- Sparrow
- Sparrow
- Spellberg
- Tiller
- US Food and Drug Administration
- Wang
- Wang-Lin
- Wilcox
- Wrammert
- Xu
- Zhu
- Zhu
- Zhu
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study